%0 Journal Article 
%A Román Cheuque, R.
%A Navarro Navarro, Irene
%A Jiménez Gallo, D.
%A Linares Barrios, Mario Dionisio
%T Alirocumab-Associated Lichenoid Reaction: A Case Report

%D 2024
%@ 0001-7310

%U http://hdl.handle.net/10498/33757
%X Lichenoid eruptions (LE) pose a real diagnostic challenge dueto their clinical and histopathological similarity to lichenplanus. Inducers are varied being drug-induced lichenoideruption (DILE) a common entity, particularly in an eracharacterized by the emergence of biologic or targeted ther-apies. This is the case of an alirocumab-induced lichenoideruption, a proprotein convertase subtilisin/kexin type 9(PCSK-9) inhibitor used to treat dyslipidemia, a drug rarelyassociated with local skin adverse reactions and exception-ally with urticaria, or vasculitis.
%K Alirocumab
%K lichenoid eruption
%~ Universidad de Cádiz